Found: 5
Select item for more details and to access through your institution.
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 2, p. 397, doi. 10.1007/s10549-018-5017-2
- By:
- Publication type:
- Article
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02754-5
- By:
- Publication type:
- Article
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02754-5
- By:
- Publication type:
- Article
Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer.
- Published in:
- Oncology, 2001, v. 60, n. 4, p. 303, doi. 10.1159/000058524
- By:
- Publication type:
- Article
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.781121
- By:
- Publication type:
- Article